CLINICAL_TRIALS
trial_result
· 2021-05-18
Clinical Trial Update: AURA-LV: Aurinia Urinary Protein Reduction Active - Lupus With Voclosporin (AURA-LV) [Phase 2]
Summary
Phase 2 trial update for voclosporin in lupus nephritis (AURA-LV) has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aurinia Pharmaceuticals Inc. | Conditions: Lupus Nephritis | Phase 2 | Status: COMPLETED | Results posted: 2021-05-18